1. Aliment Pharmacol Ther. 2020 Jan;51(1):199-200. doi: 10.1111/apt.15509.

Commentary: advances in the pharmacotherapy of NASH-anti-diabetic drugs and 
beyond.

Horn P(1)(2)(3), Newsome PN(1)(2)(3).

Author information:
(1)National Institute for Health Research Biomedical Research Centre, University 
Hospitals Birmingham NHS Foundation Trust, University of Birmingham, Birmingham, 
UK.
(2)Centre for Liver and Gastrointestinal Research, Institute of Immunology and 
Immunotherapy, University of Birmingham, Birmingham, UK.
(3)Liver Unit, University Hospitals Birmingham NHS Foundation Trust, Birmingham, 
UK.

Comment on
    Aliment Pharmacol Ther. 2004 Mar 1;19(5):537-44.

DOI: 10.1111/apt.15509
PMID: 31850557 [Indexed for MEDLINE]
